Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis
A Lin, SJ Wood, B Nelson, WJ Brewer, D Spiliotacopoulos, A Bruxner, C Broussard, C Pantelis, AR Yung
Schizophrenia Research | ELSEVIER SCIENCE BV | Published : 2011
Awarded by NHMRC
This project was supported by NHMRC Program Grants (#350241 and 566529) and the Colonial Foundation. SJW and WJB are supported by National Health and Medical Research Council (NHMRC) Career Development Awards. BN is supported by a Ronald Phillip Griffith Fellowship and a NARSAD Young Investigator Award.CP has received research funding from Janssen-Cilag, Eli-Lilly, Hospira (Mayne) and AstraZeneca, and has acted as a consultant for Janssen-Cilag, Eli-Lilly, Hospira (Mayne), AstraZeneca, Pfizer, Schering and Plough. ARY has received honoraria and travel support from AstraZeneca, Eli-Lilly, Bristol Meyer Squibb and Janssen-Cilag. Other authors have no conflicts of interest.